Grufity logo
Grufity logo

Latest Parkman Healthcare Partners LLC Stock Portfolio

$969Million– No. of Holdings #89

Parkman Healthcare Partners LLC Performance:
2026 Q1: -8.85%YTD: -8.85%2025: 22.7%
Performance for 2026 Q1 is -8.85%, and YTD is -8.85%, and 2025 is 22.7%.

About Parkman Healthcare Partners LLC and 13F Hedge Fund Stock Holdings

Parkman Healthcare Partners LLC is a hedge fund based in Stamford, CT. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Parkman Healthcare Partners LLC reported an equity portfolio of $969.6 Millions as of 31 Mar, 2026.

The top stock holdings of Parkman Healthcare Partners LLC are SYK, DXCM, KALV. The fund has invested 5.2% of it's portfolio in STRYKER CORPORATION and 4.5% of portfolio in DEXCOM INC.

The fund managers got completely rid off MASIMO CORP (MASI), TERNS PHARMACEUTICALS INC (TERN) and QIAGEN NV (QGEN) stocks. They significantly reduced their stock positions in MAZE THERAPEUTICS INC, MCKESSON CORP (MCK) and ADMA BIOLOGICS INC (ADMA). Parkman Healthcare Partners LLC opened new stock positions in ELI LILLY & CO (LLY), QIAGEN NV (QGEN) and ENVISTA HOLDINGS CORPORATION (NVST). The fund showed a lot of confidence in some stocks as they added substantially to COMPASS PATHWAYS PLC (CMPS), BUTTERFLY NETWORK INC (BFLY) and STRUCTURE THERAPEUTICS INC.
Parkman Healthcare Partners LLC Equity Portfolio Value
Last Reported on: 15 May, 2026

Parkman Healthcare Partners LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Parkman Healthcare Partners LLC made a return of -8.85% in the last quarter. In trailing 12 months, it's portfolio return was 15.73%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
eli lilly & co31,838,800
qiagen nv20,020,000
envista holdings corporation18,055,700
abbvie inc16,311,800
illumina inc13,604,200
idexx labs inc8,428,350
erasca inc6,580,440
tango therapeutics inc5,567,380
New stocks bought by Parkman Healthcare Partners LLC

Additions

Ticker% Inc.
compass pathways plc457
butterfly network inc439
structure therapeutics inc321
agios pharmaceuticals inc305
ultragenyx pharmaceutical in278
xenon pharmaceuticals inc222
alphatec hldgs inc197
ptc therapeutics inc169
Additions to existing portfolio by Parkman Healthcare Partners LLC

Reductions

Ticker% Reduced
maze therapeutics inc-84.78
mckesson corp-65.13
kiniksa pharmaceuticals intl-61.04
adma biologics inc-58.78
quidelortho corp-44.84
alnylam pharmaceuticals inc-43.58
apogee therapeutics inc-40.27
waters corp-36.88
Parkman Healthcare Partners LLC reduced stake in above stock

Sold off

Ticker$ Sold
amicus therapeutics inc-21,178,900
precigen inc-4,191,810
day one biopharmaceuticals i-6,016,470
mannkind corp-3,630,820
terns pharmaceuticals inc-25,083,400
qiagen nv-22,231,000
rapid micro biosystems inc-1,027,950
certara inc-3,072,490
Parkman Healthcare Partners LLC got rid off the above stocks

Sector Distribution

Parkman Healthcare Partners LLC has about 87.2% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare87.2
Others12.5

Market Cap. Distribution

Parkman Healthcare Partners LLC has about 38% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • SMALL-CAP
  • MID-CAP
  • UNALLOCATED
  • MEGA-CAP
  • MICRO-CAP
Category%
LARGE-CAP33
SMALL-CAP26.7
MID-CAP21.3
UNALLOCATED12.5
MEGA-CAP5
MICRO-CAP1.6

Stocks belong to which Index?

About 74.4% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • S&P 500
  • Others
Index%
RUSSELL 200039.7
S&P 50034.7
Others25.6
Top 5 Winners (%)%
OVID
ovid therapeutics inc
35.4 %
CVRX
cvrx inc
32.4 %
KALV
kalvista pharmaceuticals inc
24.1 %
SLDB
solid biosciences inc
24.0 %
EWTX
edgewise therapeutics inc
23.6 %
Top 5 Winners ($)$
KALV
kalvista pharmaceuticals inc
7.2 M
XENE
xenon pharmaceuticals inc
4.3 M
kiniksa pharmaceuticals intl
3.2 M
EWTX
edgewise therapeutics inc
2.5 M
BCRX
biocryst pharmaceuticals inc
2.2 M
Top 5 Losers (%)%
upstream bio inc
-64.9 %
ARAY
accuray inc del
-52.5 %
SMFR
genedx holdings corp
-47.6 %
OPRX
optimizerx corp
-45.3 %
QTRX
quanterix corp
-44.2 %
Top 5 Losers ($)$
BSX
boston scientific corp
-15.5 M
upstream bio inc
-14.7 M
PODD
insulet corp
-11.1 M
VRDN
viridian therapeutics inc
-7.8 M
EYPT
eyepoint inc
-6.6 M

Parkman Healthcare Partners LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Parkman Healthcare Partners LLC

Parkman Healthcare Partners LLC has 89 stocks in it's portfolio. About 34.7% of the portfolio is in top 10 stocks. BSX proved to be the most loss making stock for the portfolio. KALV was the most profitable stock for Parkman Healthcare Partners LLC last quarter.

Last Reported on: 15 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions